Feed:All articles/Pretty: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
No edit summary
Line 3,232: Line 3,232:
             "title" : "Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke",
             "title" : "Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke",
             "pmid" : "18815396"
             "pmid" : "18815396"
        },
        {
            "timestamp" : "2024-06-27T17:56:09Z",
            "briefDesignDescription" : "Levetiracetam vs. phenytoin in status epilepticus",
            "fulltexturl" : "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30724-X/fulltext",
            "pageid" : 4086,
            "pdfurl" : "https://www.thelancet.com/action/showPdf?pii",
            "trainingLevel" : "Resident",
            "citation" : "Lyttle MD, <i>et al</i>. \"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.\". <i>Lancet</i>. 2019. 393(10186):2125-2134.",
            "subspecialties" : "Emergency Medicine;Pediatrics;Neurology",
            "expansion" : "Emergency treatment with Levetiracetam or Phenytoin in convulsive Status Epilepticus in children",
            "statusUsableDate" : "2024-05-16",
            "briefResultsDescription" : "Levetiracetam is non-inferior to phenytoin",
            "published" : "2019-05-25",
            "pageName" : "EcLiPSE",
            "diseases" : "Status Epilepticus",
            "abbreviation" : "EcLiPSE",
            "title" : "Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.",
            "pmid" : "31005385"
         },
         },
         {
         {
Bots, editor, reviewer, Administrators
13,941

edits

Navigation menu